Hemoglobin Hakkari: an autosomal dominant form of beta thalassemia with inclusion bodies arising from de novo mutation in exon 2 of beta globin gene

Pediatr Blood Cancer. 2010 Feb;54(2):332-5. doi: 10.1002/pbc.22167.

Abstract

Certain beta globin gene mutations produce a thalassemia major phenotype in the heterozygous state. While most such patients have thalassemia intermedia, we describe a young Guatemalan child with a de novo mutation in the beta globin gene, codon 31 T --> G (Hemoglobin Hakkari), who developed severe anemia at the age of 10 months and remains transfusion-dependent. The substitution of B13 leucine with arginine in the beta globin results in alteration of a critical heme contact point resulting in an extremely unstable variant hemoglobin and a clinical picture that is characterized by ineffective erythropoiesis and numerous intracytoplasmic inclusions within the erythrocyte precursors of the bone marrow. .

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Guatemala
  • Hemoglobins, Abnormal / genetics*
  • Humans
  • Inclusion Bodies
  • Infant
  • Male
  • Point Mutation*
  • beta-Globins / genetics*
  • beta-Thalassemia / genetics*
  • beta-Thalassemia / pathology

Substances

  • Hemoglobins, Abnormal
  • beta-Globins